Claire Cartery

Valenciennes, FR 
Valenciennes, FR 

Overview

Claire Cartery practices practicing medicine in Valenciennes, France.

Her clinical expertise encompasses Thrombocytopenia, Interstitial Nephritis, Cerebral Hypoxia, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.

She is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Valenciennes, France
Other Locations
Bordeaux, France
Strasbourg, France
Tours, France
Paris, France
Toulouse, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3
View 1 Less Clinical Trial

19 Total Publications

Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab era.
Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab era.
Journal: Research and practice in thrombosis and haemostasis
Published: August 22, 2025

Frequently Asked Questions about Claire Cartery

Is Claire Cartery a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Claire Cartery is classified as an Experienced expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claire Cartery participate in research or clinical trials?

Yes. Claire Cartery has published 19 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Claire Cartery's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cartery's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile